382 related articles for article (PubMed ID: 29111262)
1. Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination.
Lee JY; Kim MJ; Deliyanti D; Azari MF; Rossello F; Costin A; Ramm G; Stanley EG; Elefanty AG; Wilkinson-Berka JL; Petratos S
EBioMedicine; 2017 Nov; 25():122-135. PubMed ID: 29111262
[TBL] [Abstract][Full Text] [Related]
2. Myelination Delay and Allan-Herndon-Dudley Syndrome Caused by a Novel Mutation in the SLC16A2 Gene.
La Piana R; Vanasse M; Brais B; Bernard G
J Child Neurol; 2015 Sep; 30(10):1371-4. PubMed ID: 25380603
[TBL] [Abstract][Full Text] [Related]
3. Disorder of thyroid hormone transport into the tissues.
Groeneweg S; Visser WE; Visser TJ
Best Pract Res Clin Endocrinol Metab; 2017 Mar; 31(2):241-253. PubMed ID: 28648511
[TBL] [Abstract][Full Text] [Related]
4. Monocarboxylate Transporter 8 Deficiency: Delayed or Permanent Hypomyelination?
Vancamp P; Demeneix BA; Remaud S
Front Endocrinol (Lausanne); 2020; 11():283. PubMed ID: 32477268
[TBL] [Abstract][Full Text] [Related]
5. A child with a deletion in the monocarboxylate transporter 8 gene: 7-year follow-up and effects of thyroid hormone treatment.
Zung A; Visser TJ; Uitterlinden AG; Rivadeneira F; Friesema EC
Eur J Endocrinol; 2011 Nov; 165(5):823-30. PubMed ID: 21896621
[TBL] [Abstract][Full Text] [Related]
6. Altered behavioral performance and live imaging of circuit-specific neural deficiencies in a zebrafish model for psychomotor retardation.
Zada D; Tovin A; Lerer-Goldshtein T; Vatine GD; Appelbaum L
PLoS Genet; 2014 Sep; 10(9):e1004615. PubMed ID: 25255244
[TBL] [Abstract][Full Text] [Related]
7. Identification of Inhibitors Based on Molecular Docking: Thyroid Hormone Transmembrane Transporter MCT8 as a Target.
Shaji D
Curr Drug Discov Technol; 2021; 18(1):105-112. PubMed ID: 31774046
[TBL] [Abstract][Full Text] [Related]
8. Mutations in MCT8 in patients with Allan-Herndon-Dudley-syndrome affecting its cellular distribution.
Kersseboom S; Kremers GJ; Friesema EC; Visser WE; Klootwijk W; Peeters RP; Visser TJ
Mol Endocrinol; 2013 May; 27(5):801-13. PubMed ID: 23550058
[TBL] [Abstract][Full Text] [Related]
9. Further Insights into the Allan-Herndon-Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 Mutation.
Armour CM; Kersseboom S; Yoon G; Visser TJ
PLoS One; 2015; 10(10):e0139343. PubMed ID: 26426690
[TBL] [Abstract][Full Text] [Related]
10. Zebrafish - An emerging model to explore thyroid hormone transporters and psychomotor retardation.
Zada D; Blitz E; Appelbaum L
Mol Cell Endocrinol; 2017 Dec; 459():53-58. PubMed ID: 28274736
[TBL] [Abstract][Full Text] [Related]
11. [The importance of thyroid hormone transporters].
Braun D
Nuklearmedizin; 2015; 54(3):77-81. PubMed ID: 26105714
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological treatment and BBB-targeted genetic therapy for MCT8-dependent hypomyelination in zebrafish.
Zada D; Tovin A; Lerer-Goldshtein T; Appelbaum L
Dis Model Mech; 2016 Nov; 9(11):1339-1348. PubMed ID: 27664134
[TBL] [Abstract][Full Text] [Related]
13. [MCT8-specific thyroid hormone cell transporter deficiency: a case report and review of the literature].
López-Marín L; Martín-Belinchón M; Gutiérrez-Solana LG; Morte-Molina B; Duat-Rodríguez A; Bernal J
Rev Neurol; 2013 Jun; 56(12):615-22. PubMed ID: 23744248
[TBL] [Abstract][Full Text] [Related]
14. Psychomotor retardation caused by a defective thyroid hormone transporter: report of two families with different MCT8 mutations.
Anık A; Kersseboom S; Demir K; Catlı G; Yiş U; Böber E; van Mullem A; van Herebeek RE; Hız S; Abacı A; Visser TJ
Horm Res Paediatr; 2014; 82(4):261-71. PubMed ID: 25247785
[TBL] [Abstract][Full Text] [Related]
15. Thyroid hormone transporters and resistance.
Visser TJ
Endocr Dev; 2013; 24():1-10. PubMed ID: 23392090
[TBL] [Abstract][Full Text] [Related]
16. MCT8 deficiency in Purkinje cells disrupts embryonic chicken cerebellar development.
Delbaere J; Vancamp P; Van Herck SL; Bourgeois NM; Green MJ; Wingate RJ; Darras VM
J Endocrinol; 2017 Feb; 232(2):259-272. PubMed ID: 27879339
[TBL] [Abstract][Full Text] [Related]
17. Clinical course and images of four familial cases of Allan-Herndon-Dudley syndrome with a novel monocarboxylate transporter 8 gene mutation.
Kobayashi S; Onuma A; Inui T; Wakusawa K; Tanaka S; Shimojima K; Yamamoto T; Haginoya K
Pediatr Neurol; 2014 Sep; 51(3):414-6. PubMed ID: 25160547
[TBL] [Abstract][Full Text] [Related]
18. Brain Gene Expression in Systemic Hypothyroidism and Mouse Models of MCT8 Deficiency: The Mct8-Oatp1c1-Dio2 Triad.
Morte B; Gil-Ibañez P; Heuer H; Bernal J
Thyroid; 2021 Jun; 31(6):985-993. PubMed ID: 33307956
[No Abstract] [Full Text] [Related]
19. Clinical and Molecular Characteristics of SLC16A2 (MCT8) Mutations in Three Families with the Allan-Herndon-Dudley Syndrome.
Novara F; Groeneweg S; Freri E; Estienne M; Reho P; Matricardi S; Castellotti B; Visser WE; Zuffardi O; Visser TJ
Hum Mutat; 2017 Mar; 38(3):260-264. PubMed ID: 27805744
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of monocarboxylate transporter 8 mutations in Japanese Allan-Herndon-Dudley syndrome patients.
Islam MS; Namba N; Ohata Y; Fujiwara M; Nakano C; Takeyari S; Miyata K; Nakano Y; Yamamoto K; Nakayama H; Kitaoka T; Kubota T; Ozono K
Endocr J; 2019 Jan; 66(1):19-29. PubMed ID: 30369548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]